|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| 06-023: The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II |
|
|
|
|
€ 2 880,00 |
Editeur
: |
BioInformatics |
Langue
: |
Anglais |
Date de publication : |
Juin 2006 |
Taille du document : |
205 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 33 pages | Mai 2005 | Anglais
|
|
|
| Main
focus: |
customer service,customer services,tourism
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
united kingdom,france |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pain Therapeutics: A Strategic Re-evaluation. 198 pages | Août 2000 |
Pain management, though not a life-threatening disease, will have its proper place in the future healthcare system because the disability and economic loss in addition to personal suffering caused |
955,00 €
|
| |
| |
Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment 148 pages | |
Obesity Drug Markets in the US and EUAnalysis of product pipelines and competitive environmentBusiness Intelligence for the Pharmaceutical IndustryBusiness Insights' portfolio of healthcare management |
3 068,00 €
|
| |
| |
Regulatory Affairs: Paths to Approval 113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio |
795,00 €
|
| |
| |
MarketWatch: Biotechnology 32 pages | |
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains th |
160,00 €
|
| |
| |
Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population 193 pages | |
IntroductionWith a considerable patient potential and large medical unmet need, the untapped fibromyalgia market represents a lucrative opportunity for pharmaceutical companies. Estimated to total |
12 160,00 €
|
| |
| |
Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead 161 pages | |
IntroductionVaccines have re-emerged as successful revenue generators for Big Pharma, with adults and the elderly now increasingly coming into focus as the next big opportunity in this sector. An a |
12 320,00 €
|
| |
| |
Top Ten and Emerging Pharmaceutical markets 214 pages | Juillet 1999 |
Introduction : Provides the background to the report by identifying the major trends within global healthcare markets and how these interact and influence the markets for pharmaceuticals. Mar |
795,00 €
|
| |
| |
The Pharmaceutical Outsourcing Outlook 1998-2003 199 pages | Juin 1999 |
The streamlining of pharmaceutical companies that has taken place in recent years has allowed them to focus resources and investment on core specialities. This, in turn, has led to a greater re |
795,00 €
|
| |
| |
Healthcare In Scotland 52 pages | Mai 2000 |
The Scottish Presentation Includes:- The Structure Of The NHS In Scotland- The Funding Of The NHS In Scotland- Distribution Of The NHS Budget In Scotland- Segmentation Of Expenditure - Total Capital E |
327,00 €
|
| |
| |
Global Pharmaceutical: a market, company and disease analysis 150 pages | Octobre 1998 |
What will drive pharmaceutical market growth into the 21st Century? What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies ar |
795,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| 06-023: The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II |
|
|
This 2006 report compares trends over time against the 2004 report, as well as providing additional analyses. This report will help suppliers better understand how their antibodies are used and what types of product their customers need by scientific application.
With over 325 commercial suppliers of antibodies, selecting just the right antibody company brings to mind the famous lock and key analogy of antibody-antigen binding—how do scientists find the perfect match? BioInformatics LLC surveyed nearly 1,000 life scientists worldwide about the types of catalog antibodies that they use and their opinions of commercial suppliers.
Building upon the best-selling 2004 market research report, The Market for Antibodies: Keys to Success for Commercial Suppliers, this 2006 report compares trends over time against the 2004 report, as well as providing additional analyses. This report will help suppliers better understand how their antibodies are used and what types of product their customers need by scientific application. In addition, segmentation analysis and trend comparisons will allow suppliers to understand how the antibodies market is changing and what important differences exist between segments. Market growth data, based on changes since the 2004 report and anticipated future needs, will allow suppliers to track the market performance and project future sales.
This report will help suppliers understand their competitive position, validate their own internal market share estimates, and provide the basis for internal market size calculations. This information will also help suppliers better understand their strengths and weaknesses as compared to their competitors and gauge their brand’s overall performance in the antibodies market. Report Objectives: From the perspective of researchers who use commercial, pre-made catalog antibodies, the primary objectives of this report are as follows:
* Reveal market specific differences in usage of antibody-based techniques by segmentation analysis * Determine market share by usage rates for different market segments and geographic regions * Assess market growth potential * Identify leading suppliers of commercial, pre-made catalog antibodies and those suppliers that differentiate themselves through product quality and customer service * Highlight market factor(s) that influence a customer’s decision to purchase one brand of pre-made catalog antibodies over another * Provide insights into which product attributes contribute to customer satisfaction and customer dissatisfaction * Measure customer loyalty via respondents’ willingness to promote a particular brand * Calculate a customer value score for segmented customer profiles * Evaluate brand health of the top suppliers based upon key performance metrics related to promotion, products, price, placement and service
Note: Objectives in black will include a trend analysis, comparing 2004 to 2006 data. Objectives in blue are new features of this year’s report.
|
|
This 2006 report compares trends over time against the 2004 report, as well as providing additional analyses. This report will help suppliers better understand how their antibodies are used and what types of product their customers need by scientific application.
With over 325 commercial suppliers of antibodies, selecting just the right antibody company brings to mind the famous lock and key analogy of antibody-antigen binding—how do scientists find the perfect match? BioInformatics LLC surveyed nearly 1,000 life scientists worldwide about the types of catalog antibodies that they use and their opinions of commercial suppliers.
Building upon the best-selling 2004 market research report, The Market for Antibodies: Keys to Success for Commercial Suppliers, this 2006 report compares trends over time against the 2004 report, as well as providing additional analyses. This report will help suppliers better understand how their antibodies are used and what types of product their customers need by scientific application. In addition, segmentation analysis and trend comparisons will allow suppliers to understand how the antibodies market is changing and what important differences exist between segments. Market growth data, based on changes since the 2004 report and anticipated future needs, will allow suppliers to track the market performance and project future sales.
This report will help suppliers understand their competitive position, validate their own internal market share estimates, and provide the basis for internal market size calculations. This information will also help suppliers better understand their strengths and weaknesses as compared to their competitors and gauge their brand’s overall performance in the antibodies market. Report Objectives: From the perspective of researchers who use commercial, pre-made catalog antibodies, the primary objectives of this report are as follows:
* Reveal market specific differences in usage of antibody-based techniques by segmentation analysis * Determine market share by usage rates for different market segments and geographic regions * Assess market growth potential * Identify leading suppliers of commercial, pre-made catalog antibodies and those suppliers that differentiate themselves through product quality and customer service * Highlight market factor(s) that influence a customer’s decision to purchase one brand of pre-made catalog antibodies over another * Provide insights into which product attributes contribute to customer satisfaction and customer dissatisfaction * Measure customer loyalty via respondents’ willingness to promote a particular brand * Calculate a customer value score for segmented customer profiles * Evaluate brand health of the top suppliers based upon key performance metrics related to promotion, products, price, placement and service
Note: Objectives in black will include a trend analysis, comparing 2004 to 2006 data. Objectives in blue are new features of this year’s report.
|
|
|
PPLSEN
|
|
|
|
|